FERMENTA — Fermenta Biotech Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual income statement for Fermenta Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,985	3,499	3,357	4,695	5,254
Cost of Revenue
Gross Profit	2,133	1,683	1,733	2,792	3,335
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,626	3,880	3,400	3,789	4,404
Operating Profit	359	-381	-43.1	905	850
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	269	-519	-98.7	832	959
Provision for Income Taxes
Net Income After Taxes	151	-536	-240	764	703
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	154	-515	-231	769	718
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	154	-515	-231	769	718
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.33	-11.4	-6.24	27.9	22.8
Dividends per Share